OR L'Oreal SA

L’ORÉAL SUCCESSFULLY PRICES A 1.25 BILLION EURO DUAL TRANCHE BOND

L’ORÉAL SUCCESSFULLY PRICES A 1.25 BILLION EURO DUAL TRANCHE BOND

NEWS

RELEASE

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, JAPAN OR AUSTRALIA

L’ORÉAL SUCCESSFULLY PRICES A 1.25 BILLION EURO DUAL TRANCHE BOND

Clichy, 29 October 2024 – L’Oréal today announces that it has successfully priced a public bond offering for an aggregate nominal amount of €1.25 billion.

The offering is composed of two tranches:

- A €750 million 3-year fixed rate bond paying a coupon of 2.50 % p.a.

- A €500 million 7-year fixed rate bond paying a coupon of 2.875 % p.a.

The net proceeds of the bonds will be used by the Issuer for general corporate purposes, including to refinance in part the acquisition of Galderma stake.

The bonds, which are rated AA (Stable) by S&P and Aa1 (Stable) by Moody’s, will be admitted to trading on Euronext Paris from the settlement date, which is scheduled to be 6 November 2024.

BNP Paribas, Citi and Deutsche Bank are acting as Global Coordinators. BofA Securities, Crédit Agricole CIB, and J.P. Morgan are acting as Active Joint Bookrunners. 

About L’Oréal

For 115 years, L’Oréal, the world’s leading beauty player, has devoted itself to one thing only: fulfilling the beauty aspirations of consumers around the world. Our purpose, to create the beauty that moves the world, defines our approach to beauty as essential, inclusive, ethical, generous and committed to social and environmental sustainability. With our broad portfolio of 37 international brands and ambitious sustainability commitments in our L’Oréal for the Future programme, we offer each and every person around the world the best in terms of quality, efficacy, safety, sincerity and responsibility, while celebrating beauty in its infinite plurality.

With more than 90,000 committed employees, a balanced geographical footprint and sales across all distribution networks (ecommerce, mass market, department stores, pharmacies, perfumeries, hair salons, branded and travel retail), in 2023 the Group generated sales amounting to 41.18 billion euros. With 20 research centers across 11 countries around the world and a dedicated Research and Innovation team of over 4,000 scientists and 6,400 Digital talents, L’Oréal is focused on inventing the future of beauty and becoming a Beauty Tech powerhouse. More information on /en/mediaroom

"This press release does not constitute an offer of sale or solicitation of an offer to purchase L'Oréal shares. If you wish to obtain more comprehensive information about L'Oréal, please refer to the public documents registered in France with the Autorité des Marchés Financiers, also available in English on our website -finance.com.

This press release may contain forecast information. While the Company believes that these statements are based on reasonable assumptions as of the date of publication of this press release, they are by nature subject to risks and uncertainties which may lead to a discrepancy between the actual figures and those indicated or suggested in these statements.”

CONTACTS

L’ORÉAL

Switchboard

+33 (0)1 47 56 70 00
Individual shareholders and market regulators

Pascale GUERIN

+33 (0)1 49 64 18 89

Investor relations

Eva QUIROGA

+33 (0)7 88 14 22 65

  
Media



 



Brune DIRICQ

+33 (0)6 63 85 29 87





 



Christine BURKE

+33 (0)6 75 54 38 15

For further information, please contact your bank, stockbroker of financial institution (I.S.I.N. code:  FR000012031) and consult your usual newspapers or magazines or the Internet site for shareholders and investors, , the L’Oréal Finance app or call the toll-free number from France: 0 800 66 66 66. 0 800 66 66 66

Follow us on LinkedIn

Follow us on Instagram

Attachment



EN
30/10/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on L'Oreal SA

 PRESS RELEASE

L’ORÉAL SUCCESSFULLY PRICES A 1.25 BILLION EURO DUAL TRANCHE BOND

L’ORÉAL SUCCESSFULLY PRICES A 1.25 BILLION EURO DUAL TRANCHE BOND NEWS RELEASE NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, JAPAN OR AUSTRALIA L’ORÉAL SUCCESSFULLY PRICES A 1.25 BILLION EURO DUAL TRANCHE BOND Clichy, 29 October 2024 – L’Oréal today announces that it has successfully priced a public bond offering for an aggregate nominal amount of €1.25 billion. The offering is composed of two tranches: - A €750 million 3-year fixed rate bond paying a coupon of 2.50 % p.a. - A €500 million 7-year fixed rate bond paying a co...

 PRESS RELEASE

L’ORÉAL RÉALISE AVEC SUCCÈS UNE ÉMISSION OBLIGATAIRE EN DEUX TRANCHES ...

L’ORÉAL RÉALISE AVEC SUCCÈS UNE ÉMISSION OBLIGATAIRE EN DEUX TRANCHES POUR UN MONTANT TOTAL DE 1,25 MILLIARD D’EUROS COMMUNIQUÉ NE PAS DIFFUSER, PUBLIER OU DISTRIBUER, DIRECTEMENT OU INDIRECTEMENT, AUX ETATS-UNIS, AU CANADA, AU JAPON OU EN AUSTRALIE L’ORÉAL RÉALISE AVEC SUCCÈS UNE ÉMISSION OBLIGATAIRE EN DEUX TRANCHES POUR UN MONTANT TOTAL DE 1,25 MILLIARD D’EUROS Clichy, le 29 octobre 2024 – L’Oréal a procédé aujourd’hui avec succès au placement d’une émission obligataire d’un montant nominal total de 1,25 milliard d’euros. L’offre est composée de deux tranches :- Une tranche de 750...

Cedric Rossi ... (+4)
  • Cedric Rossi
  • Clement Genelot
  • Loic Morvan
  • Philippine Adam

On the shelves now: Consumer Weekly #45

In this Consumer Weekly newsletter, we provide a brief overview of the key factors affecting our Consumer coverage, from Luxury & Consumer goods to Retail & E-commerce and Food & Ingredients. This week we look at spending patterns in Europe, which show a clear reallocation towards the f

Benoit Valleaux ... (+2)
  • Benoit Valleaux
  • Steven Gould

ODDO BHF SECURITIES MORNING NEWS – DETAILED COMMENTS 10/23/2024

Last week, we organised an Expert Access event on multiple sclerosis (MS) with the participation of Dr Géraldine Androdias, a neurologist at Lyon University Hospital. Dr Androdias presented the key points of the ECTRIMS 2024 conference, as well as new trends in treating the illness. We note an unmet need in the primary progressive and secondary progressive forms, a real interest for the BTKi class with the greater penetration of the blood-brain barrier, and expectations for the anti-C...

Benoit Valleaux ... (+2)
  • Benoit Valleaux
  • Steven Gould

ODDO BHF SECURITIES MORNING NEWS – COMMENTAIRES DETAILLES 23/10/2024

Nous avons organisé la semaine dernière un Expert Access autour de la sclérose en plaques (SEP) avec la participation du Dr Géraldine Androdias, médecin neurologue au CHU de Lyon. Le Dr Androdias a présenté les points saillants du congrès de l’ECTRIMS 2024 ainsi que les nouvelles tendances dans la prise en charge de la maladie. Nous retenons un besoin insatisfait dans les formes progressives et secondairement progressives, un vrai intérêt de la classe des BTKi avec le passage accru de...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch